Travere Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Travere Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2012 to Q2 2024.
  • Travere Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 352 %, a 12.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 352 -50 -12.4% Jun 30, 2024
Q1 2024 371 -47.4 -11.3% Mar 31, 2024
Q4 2023 420 -13.2 -3.06% Dec 31, 2023
Q3 2023 423 -44.6 -9.54% Sep 30, 2023
Q2 2023 402 -92.7 -18.7% Jun 30, 2023
Q1 2023 419 -97.5 -18.9% Mar 31, 2023
Q4 2022 433 -110 -20.3% Dec 31, 2022
Q3 2022 468 -74.7 -13.8% Sep 30, 2022
Q2 2022 495 -83.3 -14.4% Jun 30, 2022
Q1 2022 516 -96.2 -15.7% Mar 31, 2022
Q4 2021 543 -51.6 -8.68% Dec 31, 2021
Q3 2021 543 -52.7 -8.85% Sep 30, 2021
Q2 2021 578 +23.9 +4.31% Jun 30, 2021
Q1 2021 613 +106 +21% Mar 31, 2021
Q4 2020 595 +118 +24.8% Dec 31, 2020
Q3 2020 595 +113 +23.4% Sep 30, 2020
Q2 2020 554 +70.2 +14.5% Jun 30, 2020
Q1 2020 506 +80.9 +19% Mar 31, 2020
Q4 2019 476 +47.2 +11% Dec 31, 2019
Q3 2019 482 +78.7 +19.5% Sep 30, 2019
Q2 2019 484 +115 +31% Jun 30, 2019
Q1 2019 425 +14.1 +3.43% Mar 31, 2019
Q4 2018 429 +32.2 +8.11% Dec 31, 2018
Q3 2018 404 +1.58 +0.39% Sep 30, 2018
Q2 2018 369 -35.5 -8.77% Jun 30, 2018
Q1 2018 411 +13.2 +3.32% Mar 31, 2018
Q4 2017 397 -5.88 -1.46% Dec 31, 2017
Q3 2017 402 +13.3 +3.42% Sep 30, 2017
Q2 2017 405 +47.2 +13.2% Jun 30, 2017
Q1 2017 398 +131 +48.9% Mar 31, 2017
Q4 2016 403 +170 +72.9% Dec 31, 2016
Q3 2016 389 +220 +131% Sep 30, 2016
Q2 2016 357 +227 +175% Jun 30, 2016
Q1 2016 267 +147 +122% Mar 31, 2016
Q4 2015 233 +188 +420% Dec 31, 2015
Q3 2015 168 +123 +269% Sep 30, 2015
Q2 2015 130 +93.3 +254% Jun 30, 2015
Q1 2015 121 +104 +642% Mar 31, 2015
Q4 2014 44.8 +10.7 +31.3% Dec 31, 2014
Q3 2014 45.6 +5.35 +13.3% Sep 30, 2014
Q2 2014 36.8 +20.2 Jun 30, 2014
Q1 2014 16.2 -19.4 -54.5% Mar 31, 2014
Q4 2013 34.2 +33.4 Dec 31, 2013
Q3 2013 40.3 +36.5 Sep 30, 2013
Q2 2013 16.6* Jun 30, 2013
Q1 2013 35.7 Mar 31, 2013
Q4 2012 0.75* Dec 31, 2012
Q3 2012 3.79* Aug 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.